Mélanie Prague

Dr. Mélanie Prague


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in CPT: Pharmacometrics & Systems Pharmacology
Verified
Journal Article
Open access
PDF file
MPMélanie Prague
Mélanie Prague
MLMarc Lavielle
Marc Lavielle
The success of correctly identifying all the components of a nonlinear mixed‐effects model is far from straightforward: it is a question of finding the best structural model, determining the type of relationship between covariates and individual parameters, detecting possible correlations between random effects, or also modeling residual errors. We present the Stochastic Approximation for Model Building Algorithm (SAMBA) procedure and show how this algorithm can be used to speed up this process of model building by identifying at each step how best to improve some of the model components. The principle of this algorithm basically consists in “learning something” about the “best model,” even when a “poor model” is used to fit the data. A comparison study of the SAMBA procedure with Stepwise Covariate Modeling (SCM) and COnditional Sampling use for Stepwise Approach (COSSAC) show similar performances on several real data examples but with a much reduced computing time. This algorithm is now implemented in Monolix and in the R packageRsmlx.

8 July 2022 in eLife
Verified
Journal Article
Open access
MAMarie Alexandre
Marie Alexandre
RMRomain Marlin
Romain Marlin
MPMélanie Prague
Mélanie Prague
SCSeverin Coleon
Severin Coleon
NKNidhal Kahlaoui
Nidhal Kahlaoui
RTRodolphe Thiébaut
Rodolphe Thiébaut
The definition of correlates of protection is critical for the development of next-generation SARS-CoV-2 vaccine platforms. Here, we propose a model-based approach for identifying mechanistic correlates of protection based on mathematical modelling of viral dynamics and data mining of immunological markers. The application to three different studies in non-human primates evaluating SARS-CoV-2 vaccines based on CD40-targeting, two-component spike nanoparticle and mRNA 1273 identifies and quantifies two main mechanisms that are a decrease of rate of cell infection and an increase in clearance of infected cells. Inhibition of RBD binding to ACE2 appears to be a robust mechanistic correlate of protection across the three vaccine platforms although not capturing the whole biological vaccine effect. The model shows that RBD/ACE2 binding inhibition represents a strong mechanism of protection which required significant reduction in blocking potency to effectively compromise the control of viral replication.

24 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
MPMélanie Prague
Mélanie Prague
LWLinda Wittkop
Linda Wittkop
ACAnnabelle Collin
Annabelle Collin
DDDan Dutartre
Dan Dutartre
QCQuentin Clairon
Quentin Clairon
BHBoris Hejblum
Boris Hejblum
We developed a multi-level model of the French COVID-19 epidemic at the regional level. We rely on a global extended Susceptible-Exposed-Infectious-Recovered (SEIR) mechanistic model as a simplified representation of the average epidemic process, with the addition of region specific random effects. Combining several French public datasets on the early dynamics of the epidemic, we estimate region-specific key parameters conditionally on this mechanistic model through Stochastic Approximation Expectation Maximization (SAEM) optimization using Monolix software. We thus estimate the basic reproductive numbers by region before lockdown (with a national average at 2.81 with 95% Confidence Interval [2.58; 3.07]), attack rates (i.e. percentages of infected people) over time per region which range between 1.9% and 9.9% as of May 11 th , 2020, and the impact of nationwide lockdown on the infection rate which decreased the transmission rate by 76% towards reproductive numbers ranging from 0.63 to 0.73 at the end of lockdown across regions. These results confirm the low population immunity, the strong effect of the lockdown on the dynamics of the epidemics and the need for further intervention when lifting the lockdown to avoid an epidemic rebound.

6 January 2023 in The International Journal of Biostatistics
Verified
Journal Article
Closed access
ACAnnabelle Collin
Annabelle Collin
BHBoris Hejblum
Boris Hejblum
CVCarole Vignals
Carole Vignals
LLLaurent Lehot
Laurent Lehot
RTRodolphe Thiébaut
Rodolphe Thiébaut
MPMélanie Prague
Mélanie Prague
In response to the COVID-19 pandemic caused by SARS-CoV-2, governments have adopted a wide range of non-pharmaceutical interventions (NPI). These include stringent measures such as strict lockdowns, closing schools, bars and restaurants, curfews, and barrier gestures such as mask-wearing and social distancing. Deciphering the effectiveness of each NPI is critical to responding to future waves and outbreaks. To this end, we first develop a dynamic model of the French COVID-19 epidemics over a one-year period. We rely on a global extended Susceptible-Infectious-Recovered (SIR) mechanistic model of infection that includes a dynamic transmission rate over time. Multilevel data across French regions are integrated using random effects on the parameters of the mechanistic model, boosting statistical power by multiplying integrated observation series. We estimate the parameters using a new population-based statistical approach based on a Kalman filter, used for the first time in analysing real-world data. We then fit the estimated time-varying transmission rate using a regression model that depends on the NPIs while accounting for vaccination coverage, the occurrence of variants of concern (VoC), and seasonal weather conditions. We show that all NPIs considered have an independent significant association with transmission rates. In addition, we show a strong association between weather conditions that reduces transmission in summer, and we also estimate increased transmissibility of VoC.

14 July 2019 in bioRxiv
Verified
Preprint
Open access
MPMélanie Prague
Mélanie Prague
JGJeffrey M Gerold
Jeffrey M Gerold
IBIrene Balelli
Irene Balelli
CPChloé Pasin
Chloé Pasin
JLJonathan Z Li
Jonathan Z Li
AHAlison L Hill
Alison L Hill
HIV infection can be treated but not cured with antiretroviral therapy, motivating the development of new therapies that instead target host immune responses. Three such immunotherapies were recently tested in non-human primates – a TLR7-agonist, therapeutic vaccine, and broadly-neutralizing antibody – and cured a subset of animals by preventing or controlling viral rebound after antiretrovirals were stopped. However, their mechanism of action remains unknown; for example, whether they reduced the pool of latently-infected cells versus boosted antiviral immunity, and whether they acted independently or synergistically. Here we conduct a detailed analysis of the kinetics of viral rebound after immunotherapy, and use mathematical models combined with rigorous statistical fitting to quantify the impact of these interventions on viral dynamics. We find that the vaccine reduced reactivation of latent virus by 4-fold, and boosted the avidity of antiviral immune responses by 17-fold when alone and 210-fold when combined with the TLR7-agonist. In the context of later initiation of antiretroviral therapy only, the TLR7-agonist reduced latent reservoir reactivation by 8-fold, but also slightly increased target cell availability (1.5-fold). The antibody boosted immune response avidity (8-fold) and displayed no detectable synergy with the TLR7-agonist. To predict the impact of these immunotherapies in clinical trials, we calibrated a model of HIV rebound to human treatment interruption trials and simulated the effect of adding each therapy. Overall, our results provide a framework for understanding the relative contributions of different mechanisms of preventing viral rebound and highlight the multifaceted roles of TLR7-agonists for HIV/SIV cure.

14 July 2021 in medRxiv
Verified
Preprint
Open access
PDF file
ACAnnabelle Collin
Annabelle Collin
BHBoris Hejblum
Boris Hejblum
CVCarole Vignals
Carole Vignals
LLLaurent Lehot
Laurent Lehot
RTRodolphe Thiébaut
Rodolphe Thiébaut
MPMélanie Prague
Mélanie Prague
In response to the ongoing COVID-19 pandemic caused by SARS-CoV-2, governments are taking a wide range of non-pharmaceutical interventions (NPI). These measures include interventions as stringent as strict lockdown but also school closure, bar and restaurant closure, curfews and barrier gestures i.e. social distancing. Disentangling the effectiveness of each NPI is crucial to inform response to future outbreaks. To this end, we first develop a multi-level estimation of the French COVID-19 epidemic over a period of one year. We rely on a global extended Susceptible-Infectious-Recovered (SIR) mechanistic model of the infection including a dynamical (over time) transmission rate containing a Wiener process accounting for modeling error. Random effects are integrated following an innovative population approach based on a Kalman-type filter where the log-likelihood functional couples data across French regions. We then fit the estimated time-varying transmission rate using a regression model depending on NPI, while accounting for vaccination coverage, apparition of variants of concern (VoC) and seasonal weather conditions. We show that all NPI considered have an independent significant effect on the transmission rate. We additionally demonstrate a strong effect from weather conditions which decrease transmission during the summer period, and also estimate increased transmissibility of VoCs.